David M. Goldenberg
Vorsitzender bei IBC Pharmaceuticals, Inc.
Ursprung des Netzwerks ersten Grades von David M. Goldenberg
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 38 | |
IBC Pharmaceuticals, Inc.
 IBC Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of Gilead Sciences, Inc., IBC Pharmaceuticals, Inc. is a company that produces biological products. The company is based in Morris Plains, NJ.
1
| Subsidiary | Biotechnology | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von David M. Goldenberg
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Fairleigh Dickinson University | College/University | Masters Business Admin Graduate Degree Masters Business Admin | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| Montclair State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Naimark & Associates PC | Corporate Officer/Principal Corporate Officer/Principal | ||
| Merrimack College | College/University | Undergraduate Degree Undergraduate Degree | |
| CELGENE | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Colgate University | College/University | Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
| AADI BIOSCIENCE, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Ludwig-Maximilians-Universität München | College/University | Graduate Degree Undergraduate Degree | |
| OLD API WIND-DOWN LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| MYREXIS, INC. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| New York University | College/University | Undergraduate Degree Graduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| Iona College | College/University | Masters Business Admin Undergraduate Degree | |
| BIOCLINICA INC | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| Rio Grande Renewables LLC | Founder | ||
| VERASTEM, INC. | Biotechnology | Chief Executive Officer | |
Malvern Consulting Group, Inc.
 Malvern Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Malvern Consulting Group, Inc. is engaged in pre-clinical, clinical, regulatory, quality, manufacturing, and packaging services. It also offers Medical Writing, Strategic Consulting and development services. The company was founded by Geraldine A. Henwood and is headquartered in Malvern, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Rhapsody Biologics, Inc.
 Rhapsody Biologics, Inc. BiotechnologyHealth Technology Rhapsody Biologics, Inc. develops a personalized peptide vaccine platform. It predicts and optimizes peptide vaccines for use at an individual and population level. Its platform technology encompasses a discovery system to identify immunogenic fragments of disease causing agents that will stimulate an immune response. The company was founded by Richard Paul Kivel and Ren Ee Chee in October 2009 and is headquartered in Norwell, MA. | Biotechnology | Director/Board Member | |
Atlantic Healthcare Plc
 Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| University of Bristol | College/University | Graduate Degree | |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Corporate Secretary | |
FORMA Therapeutics, Inc.
 FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Chief Operating Officer | |
| ORCHESTRA BIOMED HOLDINGS, INC. | Medical Specialties | Director/Board Member | |
| FUNCTIONAL TECHNOLOGIES CORP | Food: Major Diversified | Chairman | |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Director of Finance/CFO | |
Hawaii Biotech, Inc.
 Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | Pharmaceuticals: Other | Chief Executive Officer | |
| Cytovia Holdings, Inc. | Director/Board Member | ||
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Leversense LLC
 Leversense LLC Medical/Nursing ServicesHealth Services Leversense LLC develops next generation diagnostic biosensor technology. It intends to develop a medical device for detecting AIDS, food toxin, and mycoplasma bacteria. The company was founded by Pete A. Nagy in 2006 and is headquartered in Newtown Square, PA. | Medical/Nursing Services | Director/Board Member | |
| GELESIS INC | Biotechnology | Director/Board Member | |
OnCusp Therapeutics6
 OnCusp Therapeutics6 Miscellaneous Commercial ServicesCommercial Services OnCusp Therapeutics is a biotechnology company based in New York, NY and has subsidiaries in China. OnCusp Therapeutics specializes in developing preclinical assets to clinical proof of concept and then partnering out for commercialization in the field of oncology therapeutics. The company is committed to accelerating the advancement of oncology assets by leveraging its deep translational and clinical development expertise. OnCusp Therapeutics is backed by prominent investors including Sequoia Capital, Biotrack Capital, Oriza Seed Capital, and AIHC Capital. The company was founded in 2021 by Andy Fu, Bing Yuan, and Eric Slosberg, with Bing Yuan serving as the CEO since then. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 43 |
| Kanada | 6 |
| Vereinigtes Königreich | 3 |
| Deutschland | 2 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Finance | 3 |
| Health Services | 3 |
Operativ
| Director/Board Member | 233 |
| Corporate Officer/Principal | 94 |
| Independent Dir/Board Member | 69 |
| Chairman | 50 |
| Chief Executive Officer | 43 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Peter Hutt | 69 |
| Brian Markison | 30 |
| Khalid Islam | 29 |
| David Stack | 27 |
| Robert M. Forrester | 25 |
| Dick L. Sherman | 21 |
| Geoffrey F. Cox | 20 |
| Peter Pfreundschuh | 18 |
| Jason Aryeh | 18 |
| Scott Canute | 17 |
| Arthur Kirsch | 15 |
| Robert Oliver | 14 |
| Ivan D. Horak | 13 |
| Marvin E. Jaffe | 13 |
| Sophie Visonneau | 13 |
- Börse
- Insiders
- David M. Goldenberg
- Unternehmensverbindungen
